Researchers highlight the limitations of a specific commercially available clinical genetic test in dermatology

Earlier this year, Department of Genetics professor Joel Sax, along with Christopher McFarland, assistant professor at the Department of Genetics and Genome Sciences, and Bryan Carroll, associate professor for the Department of Dermatology, published an article titled “Limitations of the Commercially Available Gene Expression Test in Predicting Cutaneous Squamous Cell Carcinoma Metastasis and Clinical Outcomes” for the Journal of the American Academy of Dermatology.